Managing Director or Director, Equity Research Analyst, Biotechnology Oncology

Senior Biotechnology Research Analyst

BMO Capital Markets is a leading, full-service North American-domiciled financial services provider offering equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, securitization, treasury management, market risk management, debt and equity research, and institutional sales and trading. BMO Capital Markets has approximately 2,700 professionals in 33 locations around the world. The Equity Research department covers close to 900 stocks across diverse sectors. Our healthcare research team is currently searching for a Senior Biotechnology Research Analyst to lead coverage of small and mid-cap oncology companies.

The Senior Biotechnology Research Analyst is responsible for leading BMO's coverage of small and mid-cap oncology companies across modalities and development stages. The individual serves as a trusted advisor to internal and external stakeholders. The ideal candidate can translate scientific analysis and clinical data into differentiated and actionable investment theses for buy-side clients and other key stakeholders.

This role combines deep industry expertise with strategic thinking to deliver actionable insights, innovative solutions, and a high-impact client experience. A combination of exceptional writing skills, technical knowledge and skills in equity research, finance / accounting, demonstrated through relevant work and educational experiences. Candidates must have a clear and proven track record of achievement throughout their education and career. Other key responsibilities and attributes include :

• Lead coverage of small and mid-cap oncology companies, across modalities and developmental stages
• Ideate and execute on production of differentiated and timely research; provide a unique point of view on the oncology and broader biotechnology sector
• Build and maintain robust financial and probability-adjusted revenue / pipeline models for oncology companies
• Present well supported investment recommendations for covered companies, including ratings and target prices
• Ability to analyze clinical trial design and data across early and late-stage oncology trials
• Deep understanding of the drug regulatory and reimbursement environment across geographies
• Monitoring of the competitive landscape as it relates to covered companies
• Host expert calls and events with oncologists and other specialists
• Represent BMO and the Healthcare Research team at major oncology conferences
• Independently vet and assess companies for potential transactions underwritten by BMO's investment bank, including IPOs and secondary equity raises
• Form and maintain deep relationships across companies (public and private), investors, and other experts in and adjacent to the sector
• Connect companies with investors via NDRs, BMO conferences, and other events
• Acts as a trusted advisor to internal and external stakeholders
• Drive buy-side investor votes and revenue
• Acts in a leadership role to drive improved efficiency and effectiveness in the department and broader Capital Markets organization
• Collaboration with other senior research analysts for cross-sector / franchise research, events, and investor marketing
• Partnership with sales and trading professionals within BMO, timely responses and action on client requests
• Considers risk, internal controls and compliance as part of day-to-day accountabilities and adheres to policies and procedures
• Operates at a group / enterprise-wide level and serves as a senior specialist resource across BMO

Candidates should have :

Please note the base salary for this role is USD$275,000 at the Director level and USD$350,000 at the Managing Director level (subject to the candidate meeting the specific skills, experience, education, and qualification requirements).